Adjunctive Therapy in Patients with Alzheimer’s Disease: A Practical Approach

Drugs & Aging

Volumn 7, Issue 2, 1995, Pages 79-87

  Corey Bloom, Jody ^a,b,c   Galasko, Douglas ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; DEPRESSION; HUMAN; PSYCHOLOGICAL ASPECT;

AGED; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; HUMAN; HYPNOTICS AND SEDATIVES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029347141     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/00002512-199507020-00002     Document Type: Article

References (46)

1. Troublesome and disruptive behaviors in dementia
2. The progression of personality change in senile dementia of the Alzheimer’s type
3. Dementia: the experience of family caregivers
4. Psychotropic drug metabolism in old age: principles and problems of assessment
5. The natural history of mental disorder in old age
6. Psychiatric phenomena in Alzheimer’s disease
7. Antidepressant drug studies in the elderly
8. Cardiovascular effects of therapeutic doses of the tricyclic antidepressants: a review
9. An overview of fluoxetine in geriatric depression
10. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression
11. Recent pharmacologic advances in antidepressant therapy for the elderly
12. Increased activity of brain and platelet monoamine oxidase in dementia of the Alzheimer type
13. How effective and safe is continuation treatment in elderly depressed patients?
14. Stimulants in the treatment of depression: a critical overview
15. Combined MAOI, TCA and direct stimulant therapy of treatment-resistant depression
16. The use of psychostimulants in general psychiatry: a reconsideration
17. Dementia of the Alzheimer’s type and depression
18. The use of antidepressants in Alzheimer’s disease patients
19. Double-blind trial of imipramine in Alzheimer’s disease patients with and without depression
20. L-Deprenyl in Alzheimer’s disease: preliminary evidence for behavioral change with monoamine oxidase B inhibition
21. Psychosis and physical aggression in probable Alzheimer’s disease
22. Agitated behavior in the elderly: a conceptual review
23. Overview of depression and psychosis in Alzheimer’s disease
24. The psychiatric symptoms of Alzheimer’s disease
25. Behavioral disturbances in dementia of the Alzheimer’s type
26. Neuroleptics in the treatment of dementia
27. A meta-analysis of controlled trials of neuroleptic treatment in dementia
28. A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer’s disease
29. Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer’s disease
30. Treatment of agitation in the elderly
31. Anticholinergic sensitivity in patients with dementia of Alzheimer type and age-matched controls
32. Unnecessary use of tranquilizers in elderly patients
33. Dementia and antipsychotic drugs
34. Neuroleptics and the elderly
35. Tardive dyskinesia: special risk in the elderly
36. Clozapine: a novel antipsychotic agent
37. Short half-life of benzodiazepines in the elderly
38. Increased sensitivity of the elderly to the central depressant effects of diazepam
39. Low-dose oral lorazepam administration in Alzheimer’s subjects and age-matched controls
40. Geriatrics: sleep disorders and aging
41. Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents
42. Propranolol for the control of disruptive behavior in senile dementia
43. Methaqualone and chloral hydrate: preliminary comparison in geriatric patients
44. Comparison of oxazepam, flurazepam and chloral hydrate as hypnotic sedatives in geriatric patients
45. Sleep and chronobiologic disturbances in late life